[26] Consequently, it can be argued that EZH2 expression is not a uniform mechanism of aggressiveness in CLL but rather that it contributes specifically to the inferior prognosis of U-CLL. Here, EZH2 is linked to B-cell chronic lymphocytic leukemia.